Stavropoulou, Charitini; Valletti, Tommaso - In: The European Journal of Health Economics 16 (2015) 1, pp. 83-94
Compulsory licensing allows the use of a patented invention without the owner’s consent, with the aim of improving access to essential drugs. The pharmaceutical sector argues that, if broadly used, it can be detrimental to innovation. We model the interaction between a company in the North...